| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/07/2004 | US6787637 Comprises administering agents that induce beneficial |
| 09/07/2004 | US6787634 Recognizes the extracellular domain of the human ifn-r and which has neutralizing capacity against the biological properties of human type i-ifn. |
| 09/07/2004 | US6787524 Stimulating antibody dependent cellular cytotoxicity (?adcc?) to enhance elimination of ige-bearing b cells by administering anti-ige antibody which binds to membrane bound ige, but does not induce histamine release and iso |
| 09/07/2004 | US6787523 Alzheimer's disease, administering an a beta peptide and an adjuvant in a regime effective to induce an immune response comprising antibodies to the a beta peptide, the adjuvant enhancing the immune response to the a beta peptide, |
| 09/07/2004 | US6787517 Agent and methods for treating pain |
| 09/07/2004 | US6787346 Kinase capable of site-specific phosphorylation of IκBα |
| 09/07/2004 | US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 09/07/2004 | US6787324 Method and apparatus for detecting conception in animals |
| 09/07/2004 | US6787322 Integrin cell surface receptor for use as tool in the treatment of cancer |
| 09/07/2004 | US6787320 In vitro methods for determining in vivo thrombotic events |
| 09/07/2004 | US6787319 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease |
| 09/07/2004 | US6787309 Nucleotide sequences coding cardiovascular protein for use in the diagnosis and treatment chromosomal disorder |
| 09/07/2004 | US6787153 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 09/07/2004 | US6787146 Vaccines against neosporosis useful in the prevention of clinical disease and abortion in mammals. |
| 09/07/2004 | US6787144 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787143 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof |
| 09/07/2004 | US6787140 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787139 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787138 Prevention and treatment of amyloidogenic disease |
| 09/07/2004 | US6787137 Campylobacter vaccine |
| 09/07/2004 | US6787136 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 09/07/2004 | US6786726 Interactive dental restorative network |
| 09/07/2004 | CA2087006C Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 09/02/2004 | WO2004074840A1 Method for the quantitative measurement of ligands in the sample of dissolved binding proteins |
| 09/02/2004 | WO2004074516A2 Method for enhancing efficacy of preparation of monoclonal antibody |
| 09/02/2004 | WO2004074514A2 Method of diagnosis of type 2 diabetes and early onset thereof |
| 09/02/2004 | WO2004074511A1 Diagnosis and treatment of baff-mediated autoimmune diseases and cancer |
| 09/02/2004 | WO2004074491A2 Expression in plants of antibodies against enterotoxigenic escherichia coli |
| 09/02/2004 | WO2004074481A1 Glycorpotein antigen sima135 expressed in metastatic human tumor cells |
| 09/02/2004 | WO2004074455A2 Fc REGION VARIANTS |
| 09/02/2004 | WO2004074437A2 Compositions and methods for cancer immunotherapy |
| 09/02/2004 | WO2004074433A2 Rag polypeptides, nucleic acids, and their use |
| 09/02/2004 | WO2004074432A2 Antibody vaccine conjugates and uses therefor |
| 09/02/2004 | WO2004074325A2 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 09/02/2004 | WO2004074324A2 Modulation of the poliovirus receptor function |
| 09/02/2004 | WO2004074323A1 Idiotypic vaccine |
| 09/02/2004 | WO2004074310A2 Mycobacterial diagnostics |
| 09/02/2004 | WO2004073741A1 Remedy for spinal injury containing interleukin-6 antagonist |
| 09/02/2004 | WO2004073739A1 A method of diagnosis and treatment |
| 09/02/2004 | WO2004073659A2 HIV gp120 MIMOTOPE ANTIGEN |
| 09/02/2004 | WO2004073656A2 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/02/2004 | WO2004073653A2 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
| 09/02/2004 | WO2004073624A2 Contraceptive methods and compositions related to proteasomal interference |
| 09/02/2004 | WO2004073499A2 Diagnosis of primary open angle glaucoma |
| 09/02/2004 | WO2004073393A2 Immunogene adherence and method of making and using same |
| 09/02/2004 | WO2004062551A3 RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN |
| 09/02/2004 | WO2004059278A8 Methods of screening for anti-inflammatory drugs and use thereof |
| 09/02/2004 | WO2004048517A3 Method for reducing or preventing modification of a polypeptide in solution |
| 09/02/2004 | WO2004036258A3 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 09/02/2004 | WO2004024084A3 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 09/02/2004 | WO2004022717A3 Minimally immunogenic variants of humanized col-1 antibody against carcinoembryonic antigen |
| 09/02/2004 | WO2004020665A3 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases |
| 09/02/2004 | WO2004020456A3 Selecting therapeutic human monoclonal antibodies from disease-specific libraries |
| 09/02/2004 | WO2004002421A3 Method for the treatment of multiple sclerosis |
| 09/02/2004 | WO2003048302A3 Identifying anti-tumor targets or agents by lipid raft immunization and proteomics |
| 09/02/2004 | WO2003015697A3 Interleukin-2 mutants with reduced toxicity |
| 09/02/2004 | US20040172673 Expression vector comprising nucleotide sequences coding polypetide which confers resistance to pseudomonas syringae; genetic engineering and disease resistant plants |
| 09/02/2004 | US20040172667 Administration of transposon-based vectors to reproductive organs |
| 09/02/2004 | US20040171825 Human fibroblast growth factor-related compositions |
| 09/02/2004 | US20040171816 Humanized antibodies that recognize beta amyloid peptide |
| 09/02/2004 | US20040171815 treatment of diseases associated with amyloid deposits in the brain (pre-clinical Alzheimer's disease or Down's syndrome); genetic engineering |
| 09/02/2004 | US20040171814 Antigen PIPA and antibodies that bind thereto |
| 09/02/2004 | US20040171813 comprises homogenizing to produce a green juice, adjusting pH and heating, separating by centrifugation and/or resuspension, then chromatography |
| 09/02/2004 | US20040171811 for drug screening using animal models with in vitro activation; genetic engineering |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171803 Artificial protein having potentiated immunogenicity of epitope |
| 09/02/2004 | US20040171801 Nk-2 homeobox transcription factor |
| 09/02/2004 | US20040171553 Peptides fragments of colostrinin and their use |
| 09/02/2004 | US20040171551 which binds to an amino acid sequence comprising at least 5 EP motifs over a 19 amino acid segment |
| 09/02/2004 | US20040171538 Anticoagulants and their uses |
| 09/02/2004 | US20040171529 Treatment with neurotrophic factors |
| 09/02/2004 | US20040171523 Immunogenic glycopeptides, screening, preparation and uses |
| 09/02/2004 | US20040171158 Adenoviral vector incorporating zipper peptide-modified fiber protein and uses thereof |
| 09/02/2004 | US20040171155 Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 09/02/2004 | US20040171144 Increasing sperm motility |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171120 Enhanced insecticidal protein for killing bettles, moths, flies; biolgical pest control |
| 09/02/2004 | US20040171117 Anti-RANK ligand monoclonal antibodies useful in treatment of RANK ligand mediated disorders |
| 09/02/2004 | US20040171110 Novel member of the lysyl oxidase gene family |
| 09/02/2004 | US20040171105 Using enzymatic polypeptide to inactivate inhibitor of apoptosis and activate caspase for treatment and prevention of cancer, autoimmune and neurodegenerative diseases |
| 09/02/2004 | US20040171084 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 09/02/2004 | US20040171081 Identifying immunodominant epitope for elliciting immune response to treat and prevent tumors and infections; immunotherapy |
| 09/02/2004 | US20040171042 Functional assays that use theT1R1 receptor to screen for T1R1-associated taste modulators |
| 09/02/2004 | US20040171018 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040170999 Nuclear hormone receptor ligand binding domain |
| 09/02/2004 | US20040170995 for drug screening in vitro for mitogen-activated protein kinase-activated protein kinase-2 modulators using expression libraries; genetic engineering; kits |
| 09/02/2004 | US20040170993 Methods for diagnosing and treating heart disease |
| 09/02/2004 | US20040170973 DNA encoding the human serine protease EOS |
| 09/02/2004 | US20040170971 kits for detecting amplification or elevated expression for diagnosis; genetic engineering; solid phase synthesis |
| 09/02/2004 | US20040170967 Assays for detection of bacillus anthracis |
| 09/02/2004 | US20040170961 for drug screening anticancer agents; solid phase synthesis; animal models; genetic engineering; kits |
| 09/02/2004 | US20040170953 comprises using a phosphate buffer that specifically binds to hepatitis B virus; genetic engineering; kits |
| 09/02/2004 | US20040170653 recognised by CD8-positive cytotoxic T-lymphocytes as a peptide antigen and causes a CTL-induced lysis and/or apoptosis of tumor or leukemia cell; has the amino acid sequence LLGDLFGV, which corresponds to the amino acid positions 81 to 88 of the hdm2 proto-oncoprotein |
| 09/02/2004 | US20040170641 Prevention and treatment of amyloidogenic disease |
| 09/02/2004 | US20040170635 administering an inhibitor of the CD2/LFA-3 interaction, in combination with narrow band UVB radiation; especially for treating psoriasis |
| 09/02/2004 | US20040170633 Enhancing the efficacy of immunotherapies by supplementing with complement |
| 09/02/2004 | US20040170632 Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 09/02/2004 | US20040170631 Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies |